31 results on '"Connors, Jean Marie"'
Search Results
2. Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
3. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
4. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
5. How to manage coagulopathies in critically ill patients
6. ISTH guidelines for antithrombotic treatment in COVID‐19
7. Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management
8. Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
9. Recent advances in the research and management of sepsis-associated DIC
10. The coagulopathy, endotheliopathy, and vasculitis of COVID-19
11. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial
12. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump—the MAGENTUM 1 study
13. NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
14. The unique characteristics of COVID-19 coagulopathy
15. The authors reply
16. Coagulopathy of Coronavirus Disease 2019
17. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
18. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
19. Apixaban has superior effectiveness and safety compared to rivaroxaban in patients with commercial healthcare coverage: A population‐based analysis in response to CVS 2022 formulary changes
20. Factor XI Deficiency
21. Anticoagulation in COVID-19: reaction to the ACTION trial
22. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy
23. Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants
24. ISTHguidelines for antithrombotic treatment in COVID‐19
25. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19
26. Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study
27. Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study.
28. Coagulopathy of Coronavirus Disease 2019.
29. Direct Oral Anticoagulants in Clinical Practice
30. Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study.
31. Type A Aortic Dissection in a Patient on Dabigatran: Hemostasis Post Circulatory Arrest
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.